AI assistant
Sending…
HEALTHEQUITY, INC. — Director's Dealing 2022
Apr 1, 2022
30722_dirs_2022-04-01_06a59280-7b30-4e93-958f-27dd0abd54cc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEALTHEQUITY, INC. (HQY)
CIK: 0001428336
Period of Report: 2022-03-30
Reporting Person: Rosner Elimelech (EVP, Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-30 | Common Stock | A | 59480 | — | Acquired | 59480 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Shares vest as to 25% of the initial award on April 1, 2023. Shares shall vest as to 6.25% thereafter on the first day of each calendar quarter for the twelve calendar quarters following April 1, 2023.
More from HEALTHEQUITY, INC.
Interim / Quarterly Report
2026
May 28
Regulatory Filings
2026
May 28
Annual Report
2026
May 13
Regulatory Filings
2026
Apr 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Annual Report
2026
Mar 17